Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months

Charles S. Haworth, Michal Shteinberg, Kevin Winthrop, Alan F Barker, Francesco Blasi, Katerina Dimakou, Lucy C. Morgan, Anne E. O'Donnell, Felix C. Ringshausen, Oriol Sibila, Rachel M. Thomson, Kevin J. Carroll, Federica Pontenani, Paola Castellani, James D. Chalmers (Lead / Corresponding author),

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)
26 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry